Bangning Yu

1.5k total citations
22 papers, 1.1k citations indexed

About

Bangning Yu is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Bangning Yu has authored 22 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Pharmacology and 4 papers in Oncology. Recurrent topics in Bangning Yu's work include Pharmacogenetics and Drug Metabolism (8 papers), Receptor Mechanisms and Signaling (4 papers) and Drug Transport and Resistance Mechanisms (3 papers). Bangning Yu is often cited by papers focused on Pharmacogenetics and Drug Metabolism (8 papers), Receptor Mechanisms and Signaling (4 papers) and Drug Transport and Resistance Mechanisms (3 papers). Bangning Yu collaborates with scholars based in United States, China and Germany. Bangning Yu's co-authors include Charles D. Nichols, David Martin, Zhi‐Rong Tan, Jaime Becnel, Zhaoqian Liu, Wei Zhang, An Wang, Yijing He, Mourad Zerfaoui and Hong‐Hao Zhou and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Bangning Yu

22 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bangning Yu United States 12 295 258 224 203 182 22 1.1k
Massimiliano Donzelli Switzerland 18 143 0.5× 168 0.7× 639 2.9× 579 2.9× 61 0.3× 25 1.5k
Angela Seeringer Germany 18 154 0.5× 261 1.0× 60 0.3× 83 0.4× 110 0.6× 30 926
Kazuyuki Inoue Japan 27 351 1.2× 301 1.2× 63 0.3× 442 2.2× 447 2.5× 96 2.3k
Nada Božina Croatia 23 423 1.4× 482 1.9× 28 0.1× 132 0.7× 355 2.0× 86 1.5k
Georg Engel Germany 14 251 0.9× 291 1.1× 26 0.1× 534 2.6× 128 0.7× 31 1.6k
Noriyuki Miyata Japan 26 72 0.2× 237 0.9× 74 0.3× 99 0.5× 61 0.3× 56 2.6k
P. R. Sundaresan United States 24 189 0.6× 65 0.3× 141 0.6× 136 0.7× 51 0.3× 72 1.9k
C. Cangiano Italy 28 102 0.3× 43 0.2× 122 0.5× 131 0.6× 81 0.4× 63 1.7k
Niels‐Erik Larsen Denmark 20 131 0.4× 94 0.4× 35 0.2× 96 0.5× 115 0.6× 44 1.1k
Arzu Gunes Sweden 15 109 0.4× 265 1.0× 28 0.1× 73 0.4× 83 0.5× 23 832

Countries citing papers authored by Bangning Yu

Since Specialization
Citations

This map shows the geographic impact of Bangning Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bangning Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bangning Yu more than expected).

Fields of papers citing papers by Bangning Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bangning Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bangning Yu. The network helps show where Bangning Yu may publish in the future.

Co-authorship network of co-authors of Bangning Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Bangning Yu. A scholar is included among the top collaborators of Bangning Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bangning Yu. Bangning Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Bangning, et al.. (2021). Serotonin 5-HT2A receptor activity mediates adipocyte differentiation through control of adipogenic gene expression. Scientific Reports. 11(1). 19714–19714. 9 indexed citations
2.
Sandberg, David I., Bangning Yu, Leomar Y. Ballester, et al.. (2020). High-dose MTX110 (soluble panobinostat) safely administered into the fourth ventricle in a nonhuman primate model. Journal of Neurosurgery Pediatrics. 26(2). 127–135. 9 indexed citations
3.
Yu, Bangning, Christopher Janssen, Leomar Y. Ballester, et al.. (2020). High-Dose MTX110 (Soluble Panobinostat) Safely Administered into the Fourth Ventricle in a Nonhuman Primate Model. Neurosurgery. 67(Supplement_1). 1 indexed citations
4.
Zhu, Liang, et al.. (2020). Reducing opioid usage: a pilot study comparing postoperative selective dorsal rhizotomy protocols. Journal of Neurosurgery Pediatrics. 25(3). 305–310. 7 indexed citations
5.
Sandberg, David I., Bangning Yu, Rajan Patel, et al.. (2018). Infusion of 5-Azacytidine (5-AZA) into the fourth ventricle or resection cavity in children with recurrent posterior Fossa Ependymoma: a pilot clinical trial. Journal of Neuro-Oncology. 141(2). 449–457. 19 indexed citations
6.
Stein, Mark N., Nancy Chan, Ann W. Silk, et al.. (2017). Anticancer and immunostimulatory activity of the imipridone ONC201, a selective DRD2 antagonist, in advanced cancer patients.. Journal of Clinical Oncology. 35(15_suppl). 2586–2586. 1 indexed citations
7.
Rodríguez-Rodríguez, Lorna, Janice M. Mehnert, Ann W. Silk, et al.. (2017). Clinical activity of the selective DRD2 antagonist ONC201, an imipridone, in metastatic endometrial cancer (mEC).. Journal of Clinical Oncology. 35(15_suppl). 5592–5592. 2 indexed citations
8.
Yu, Bangning, et al.. (2013). Serotonin 5-HT2A Receptor Activation Blocks TNF-α Mediated Inflammation In Vivo. PLoS ONE. 8(10). e75426–e75426. 160 indexed citations
9.
Becnel, Jaime, Zana R. Majeed, Vi Tran, et al.. (2013). DREADDs in Drosophila: A Pharmacogenetic Approach for Controlling Behavior, Neuronal Signaling, and Physiology in the Fly. Cell Reports. 4(5). 1049–1059. 33 indexed citations
10.
Yu, Bangning, et al.. (2009). The Aporphine Alkaloid Boldine Induces Adiponectin Expression and Regulation in 3T3-L1 Cells. Journal of Medicinal Food. 12(5). 1074–1083. 15 indexed citations
11.
He, Yijing, Wei Zhang, Yao Chen, et al.. (2009). Rifampicin alters atorvastatin plasma concentration on the basis of SLCO1B1 521T>C polymorphism. Clinica Chimica Acta. 405(1-2). 49–52. 70 indexed citations
12.
Yu, Bangning & Charles D. Nichols. (2009). Serotonin 5‐HT2A receptor activity mediates adipocyte differentiation. The FASEB Journal. 23(S1). 2 indexed citations
13.
Yu, Bangning, et al.. (2008). Serotonin 5-Hydroxytryptamine2A Receptor Activation Suppresses Tumor Necrosis Factor-α-Induced Inflammation with Extraordinary Potency. Journal of Pharmacology and Experimental Therapeutics. 327(2). 316–323. 173 indexed citations
14.
Zhang, Wei, Bangning Yu, Yijing He, et al.. (2006). Role of BCRP 421C>A polymorphism on rosuvastatin pharmacokinetics in healthy Chinese males. Clinica Chimica Acta. 373(1-2). 99–103. 197 indexed citations
15.
Zhang, Wei, Yijing He, Zhaoqian Liu, et al.. (2006). Effect of SLCO1B1 genetic polymorphism on the pharmacokinetics of nateglinide. British Journal of Clinical Pharmacology. 62(5). 567–572. 84 indexed citations
16.
Wang, An, Bangning Yu, Chen‐Hui Luo, et al.. (2005). Ile118Val genetic polymorphism of CYP3A4 and its effects on lipid-lowering efficacy of simvastatin in Chinese hyperlipidemic patients. European Journal of Clinical Pharmacology. 60(12). 843–848. 66 indexed citations
17.
Luo, Chen‐Hui, An Wang, Ronghua Zhu, et al.. (2005). Gender specific association of CYP2C9*3 with hyperlipidaemia in Chinese. British Journal of Clinical Pharmacology. 60(6). 629–631. 3 indexed citations
18.
Yu, Bangning, Chen‐Hui Luo, Dan Wang, et al.. (2004). CYP2C9 allele variants in Chinese hypertension patients and healthy controls. Clinica Chimica Acta. 348(1-2). 57–61. 50 indexed citations
19.
Yu, Bangning, An Wang, Gan Zhou, et al.. (2004). T102C genetic polymorphism of the 5‐HT2A receptor in Chinese hypertensive patients and healthy controls. Clinical and Experimental Pharmacology and Physiology. 31(12). 847–849. 10 indexed citations
20.
Yu, Bangning, Guo‐Lin Chen, Nan He, et al.. (2003). PHARMACOKINETICS OF CITALOPRAM IN RELATION TO GENETIC POLYMORPHISM OF CYP2C19. Drug Metabolism and Disposition. 31(10). 1255–1259. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Massimiliano Donzelli Breakdown of academic impact, for papers by Angela Seeringer Breakdown of academic impact, for papers by Kazuyuki Inoue Breakdown of academic impact, for papers by Nada Božina Breakdown of academic impact, for papers by Georg Engel Breakdown of academic impact, for papers by Noriyuki Miyata Breakdown of academic impact, for papers by P. R. Sundaresan Breakdown of academic impact, for papers by C. Cangiano Breakdown of academic impact, for papers by Niels‐Erik Larsen Breakdown of academic impact, for papers by Arzu Gunes
Rankless by CCL
2026